Skip to main content
. 2016 Aug 1;9:4773–4783. doi: 10.2147/OTT.S103940

Figure 1.

Figure 1

Armillarikin inhibits hepatoma cell proliferation.

Notes: (A) Huh7, (B) HA22T, and (C) HepG2 HCC cells were treated with DMSO or armillarikin for 24–72 h. The relative number of viable cells was detected by MTS assay. OD values of DMSO-treated control cells were designated as 100% activity as a standard. *P<0.05, **P<0.01, and ***P<0.001 (Student’s t-test) compared with DMSO control. Data are mean ± SD.

Abbreviations: DMSO, dimethyl sulfoxide; HCC, hepatocellular carcinoma; MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium; OD, optical density.